VLS.AX ASX
Vita Life Sciences Limited
1W: +0.0%
1M: -0.4%
3M: +12.7%
YTD: +6.2%
1Y: +22.1%
3Y: +95.7%
5Y: +168.0%
A$2.72 ($1.89)
-0.04 (-1.45%)
Weekly Expected Move ±1.8%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$16M
+166.9% ▲
5Y CAGR: +16.8%
Capital Expenditures
$570K
-187.9% ▼
5Y CAGR: +45.0%
Free Cash Flow
$16M
+166.2% ▲
5Y CAGR: +16.3%
Dividends Paid
$6M
-17.6% ▼
Buybacks
$2M
-60.6% ▼
Net Change in Cash
$7M
+75.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $8M | $7M | $9M | $9M | $10M |
| Depreciation & Amort. | $409K | $599K | $512K | $612K | $1M |
| Stock-Based Comp. | $208K | $713K | $684K | $435K | $0 |
| Change in Working Capital | -$3M | -$6M | $2M | -$6M | $5M |
| Other Non-Cash Items | -$31K | $1M | -$973K | $3M | $201K |
| Operating Cash Flow | $6M | $3M | $13M | $6M | $16M |
| — Investing Activities — | |||||
| Capital Expenditures | -$155K | -$139K | -$660K | -$198K | -$570K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$155K | -$139K | -$660K | -$198K | -$570K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | -$338K | -$171K | -$286K | $0 |
| Stock Repurchased | $0 | -$311K | -$208K | -$1M | -$2M |
| Dividends Paid | -$3M | -$3M | -$3M | -$5M | -$6M |
| Other Financing | $0 | $0 | $0 | $4M | -$769K |
| Financing Cash Flow | -$4M | -$3M | -$3M | -$3M | -$9M |
| Net Change in Cash | $1M | -$205K | $9M | $4M | $7M |
| Cash End of Period | $16M | $16M | $25M | $29M | $36M |
| Free Cash Flow | $6M | $8M | $12M | $6M | $16M |